[Modern approaches to estrogen-independent growth of breast tumor].
Krasil'nikov
M A
MA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D004815:Epidermal Growth Factor / Q000378:metabolism / Q000502:physiology; D004965:Estrogen Antagonists / Q000627:therapeutic use; D020847:Estrogen Receptor Modulators; D004967:Estrogens / Q000378:metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism / Q000502:physiology; D011960:Receptors, Estrogen / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen / Q000627:therapeutic use; D014157:Transcription Factors / Q000502:physiology; D014407:Tumor Cells, Cultured
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D020847:Estrogen Receptor Modulators; D004967:Estrogens; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D014157:Transcription Factors; D013629:Tamoxifen; D004815:Epidermal Growth Factor; D019869:Phosphatidylinositol 3-Kinases